Targeted prostate cancer treatment cuts risk of side effects, study suggests
An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.
Discover more from NAIRAVOICE.COM.NG
Subscribe to get the latest posts sent to your email.